Iovance Biotherapeutics, Inc. (IOVA) Revenue Growth
Iovance Biotherapeutics, Inc. (IOVA) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2017-12-31 | N/A |
| 2018-12-31 | N/A |
| 2019-12-31 | N/A |
| 2020-12-31 | N/A |
| 2021-12-31 | N/A |
| 2022-12-31 | N/A |
| 2023-12-31 | N/A |
| 2024-12-31 | 13698.99% |
| 2025-12-31 | 60.60% |
How IOVA compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| AXSM | Axsome Therapeutics Inc. | 65.55% |
| LLY | Eli Lilly and Company | 44.70% |
| NTRA | Natera Inc. | 35.90% |
| KRYS | Krystal Biotech Inc. | 33.94% |
| PODD | Insulet Corporation | 30.73% |
These are five companies in the same sector as IOVA with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Iovance Biotherapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("IOVA", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | IOVA | $8.17 | +2.00% | 12.12M |
| 3 | ||||
| 4 | ||||
| 5 |